Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q2 2024 Earnings

8MayConfirmed

Q3 2023

Q4 2023

Q1 2024

Q2 2024

-0.45

-0.2

0.04

0.29

Details

Expected EPS

0.04881

Actual EPS

0.1

Surprise EPS

0.05

Surprise Percent

+104.88%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of 0.1 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.